A Phase II Trial of Guadecitabine Plus Atezolizumab in Metastatic Urothelial Carcinoma Progressing after Initial Immune Checkpoint Inhibitor Therapy.
pubmed(2023)
Key words
Urothelial Carcinoma,Immune Checkpoint Blockade,Combination Therapies,Cancer Immunoediting,Biomarkers for Immunotherapy
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined